Community-based multidisciplinary group intervention
Community-based multidisciplinary group intervention has been studied in 1 paper since 2023: 1 trial in people. The newest paper, Aug 11, 2023: “Multi-disciplinary community-based group intervention for fibromyalgia: a pilot randomized controlled trial”.
1 paper studies it4 findingsUpdated
See all 1 papers on community-based multidisciplinary group intervention
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Statistically significant post-intervention improvements were found in the primary outcome, perceived quality of care”
None of its findings points the other way.
- 1 lab in 1 country
- 4 of 4 findings with company ties
- Human trial1
Studies in people
1 study gave community-based multidisciplinary group intervention to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves perceived quality of careCohen's d = 0.61 for follow-up care and 0.66 for goal setting up: Improves disease-related daily functioningCohen's d = 0.70 down: Decreases depressive symptomsCohen's d = 0.87 | Randomized trial10 weeks | 60 peopleFibromyalgia | Rheumatology international, Aug 11, 2023 |
What did studies of community-based multidisciplinary group intervention find?
4Studies of community-based multidisciplinary group intervention measured 4 outcomes; the most studied are adaptive pain beliefs (1 study), depressive symptoms (1) and disease-related daily functioning (1).
Adaptive pain beliefs
upin humans1
1 study
Adaptive pain beliefs
upin humans1
Community-based multidisciplinary group intervention improves adaptive pain beliefs in humans (fibromyalgia; compared with usual care) (Cohen's d = 0.61, 0.67, 0.82 for harm, disability, and control, respectively).
“Secondary outcomes showing statistically significant improvements were disease-related daily functioning (Cohen's d = 0.70), depressive symptoms (Cohen's d = 0.87), and pain beliefs”
Human trialfibromyalgia; compared with usual care10 weeksn = 60
Rheumatology international
Depressive symptoms
downin humans1
1 study
Depressive symptoms
downin humans1
Community-based multidisciplinary group intervention decreases depressive symptoms in humans (fibromyalgia; compared with usual care) (Cohen's d = 0.87).
“Secondary outcomes showing statistically significant improvements were disease-related daily functioning (Cohen's d = 0.70), depressive symptoms (Cohen's d = 0.87)”
Human trialfibromyalgia; compared with usual care10 weeksn = 60
Rheumatology international
Disease-related daily functioning
upin humans1
1 study
Disease-related daily functioning
upin humans1
Community-based multidisciplinary group intervention improves disease-related daily functioning in humans (fibromyalgia; compared with usual care) (Cohen's d = 0.70).
“Secondary outcomes showing statistically significant improvements were disease-related daily functioning (Cohen's d = 0.70), depressive symptoms (Cohen's d = 0.87)”
Human trialfibromyalgia; compared with usual care10 weeksn = 60
Rheumatology international
Perceived quality of care
upin humans1
1 study
Perceived quality of care
upin humans1
Community-based multidisciplinary group intervention improves perceived quality of care in humans (fibromyalgia; compared with usual care) (Cohen's d = 0.61 for follow-up care and 0.66 for goal setting).
“Statistically significant post-intervention improvements were found in the primary outcome, perceived quality of care”
Human trialfibromyalgia; compared with usual care10 weeksn = 60
Rheumatology international